By: IPP Bureau
Last updated : July 15, 2026 6:33 pm
The leading healthcare stakeholders including Dr Indu Bhushan, former CEO of India’s National Health Authority discussed the ways to strengthen partnerships across healthcare ecosystem
IHH Healthcare hosted the second edition of its flagship regional leadership conference FutureHealth.Now in Singapore.
Under the theme ‘Redefining the Care Stack’, the conference brought together more than 300 leaders from government, healthcare, technology, finance and investment – including Dr Indu Bhushan, Economist and former CEO of India’s National Health Authority.
The leading healthcare stakeholders discussed how stronger partnerships across the healthcare ecosystem can better address evolving patient and healthcare ecosystem needs.
At his opening address, Ashok Pandit, Group Chief Corporate Officer, IHH Healthcare, said, “Healthcare systems today are facing pressures like never before. Demand is rising faster than capacity, costs are increasing faster than affordability, and expectations are growing faster than our systems can adapt.”
“The way we have delivered healthcare for the past 50 years will not be enough for the next 50. That is why we are redefining the care stack – bringing together people, science, technology, infrastructure, capital, policy and trust to reimagine how care is designed and delivered. Ultimately, our goal is simple – better outcomes, greater access and better value for patients,” Pandit said.
Among the conference’s key discussions was a session on balancing cost and outcomes in healthcare, featuring Dr Bhushan alongside Lawrence Lam, Chief Executive Officer, Prudential Hong Kong, and Professor Joseph Sung, Dean, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, moderated by Dr Kamal Amzan, Chief Executive Officer, IHH Healthcare Malaysia.
“Value is an outcome, cost is an input,” said Dr Indu Bhushan while adding that from a patient and society perspective, value means better health outcomes, equity and improved population health for the resources available.
He also outlined three tests he applied when deciding whether government should support new health technologies while leading India’s National Health Authority: whether the improvement is meaningful and not merely statistical, whether it is cost-effective relative to existing alternatives, and whether it improves or undermines equity of access between those who can and cannot afford it.